Slide background
LEARN MORE

THE BLOOD BASED ALGORITHMIC DETECTION SYSTEM
FOR PATIENTS AT RISK FOR LIVER DISEASE

Slide background
LEARN MORE

Designed For
Individuals who want to
monitor Their risk
of Liver disease

Slide background
Learn More

UP TO 20% OF PATIENTS WITH LIVER DISEASE
WILL DEVELOP CIRRHOSIS

NAFLD | NASH

Who we are

We improve human health by applying the science of machine learning to develop algorithms to detect disease and monitor progression.

 

What we do

Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on liver disease detection and monitoring.

 

Did You Know...

Some interesting statstics on Liver Disease
 
Global prevalence of NAFLD is approximately 25%1,
estimated Middle americans with NAFLD

1.Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcome. Hepatology 64(1): 73-84

2.Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol 107: 811–826

Our Unique Liver Diagnostics Tests

The non-invasive solution for liver health evaluations 

 
GET YOUR LIVER SCORE

The Benchmark Non-Invasive Liver Screen

Assessing 3 types of liver injury: 
1. Fat Accumulation (Steatosis) 
2. Inflammation (Activity)  
3. Scarring (Fibrosis).
The LiverFASt™ algorithm includes 9 biomarkers.

LEARN MORE
GET YOUR LIVER SCORE

Designed for Health-Conscious Individuals

Provides individuals with a low-to-high risk assessment of fatty liver (steatosis).
LiverFAST™ Select only requires age, gender and BMI.


Learn more about LiverFASt Select, the breaktrhough system to monitor your liver health.

Discover Your Liver Score Now

Knowing if your liver is healthy can save your life.
Liver disease, if detected early enough, can be treated and reversed.
The key is for you to know and take action.

Use LiverFASt or LiverFASt Select to know the conditions of your liver.

The Fibronostics Team

Meet The Team Behind LiverFASt™

 
BRETT GIFFIN
BRETT GIFFINCEO
History of significant leadership roles and accomplishments in the medical industry. [Learn More]
HAWLEY LINKESenior Director, Scientific Affairs
Senior scientist in pharmaceutical, academic, and consulting/freelance environments. [Learn More]
HAWLEY LINKE
GREG AUDA
GREG AUDACCO
Dynamic Health Technology Commercial Executive with many years of experience and extensive leadership roles in the Medical Industry. [Learn More]
Rodney CheungCIO
High-performance CIO with over 25 years of strategically using of innovative technologies.[Learn More]
Rodney Cheung

Our Blogs

Interesting information about Liver Health and Disease
 

Anything that keeps your liver from doing its job may put your life in danger.
There are many different types of liver disease. But no matter what type you have, the damage to your liver is likely to progress in a similar

...

MONDAY, June 24 (HealthDay News) -- A new study adds to growing evidence of a link between a common liver diseaseassociated with obesity and high risk for heart disease.                            

Summary: Cirrhosis was associated with increased risk of stroke, especially hemorrhagic, in a study that included a representative sample of more than 1.6 million Medicare beneficiaries, according to an article.

About FIBRONOSTICS

We are a team of life science experts, physicians, mathematicians, health IT professionals and software architects.